Colin Kruger

James Hardie investors have dumped chairwoman Anne Lloyd and two other board members in an unprecedented display of anger, and its CEO may be next.

A further plunge in US vaccination rates since the appointment of vaccine sceptic Robert F. Kennedy Jr has sparked a fresh earnings blow to biotech giant CSL.

With Tabcorp shares soaring, investors were in no mood to deny yet another multimillion-dollar CEO options package for former AFL boss Gillon McLachlan.

With Tabcorp shares soaring, investors were in no mood to deny yet another multimillion-dollar CEO options package for former AFL boss Gillon McLachlan.

The shock allegations from retail legend Solomon Lew this week point to a bigger headache for his multibillion-dollar retail empire.

The gambling giant wants to end a high-profile legal dispute with its former chief executive that could get ugly if it goes the distance.

Alan Joyce’s former lieutenant at Qantas departed Virgin Australia in style with a payout that dwarfs her former boss’s controversial exit package.

Nothing highlights the US president’s trade delusions better than his victory over Australia’s beef ban. Record exports are now flowing in the opposite direction to what he intended.

Tracking app Life360 has shed its stalker image, and delivered a 1000 per cent return for local investors by leaning into its uncomfortable selling point: you can track your kids 24/7.

CSL is battling the US president’s threat against big pharma and the vaccine scepticism of his health tsar, but that’s not why its shares plunged on Tuesday.